|
US3391141A
(en)
|
1966-07-07 |
1968-07-02 |
Bristol Myers Co |
Synthetic cephalosporins
|
|
US5006334A
(en)
|
1973-05-07 |
1991-04-09 |
The Ohio State University |
Antigenic modification of polypeptides
|
|
US4691006A
(en)
|
1983-03-04 |
1987-09-01 |
Ohio State University |
Antigenic modification of polypeptides
|
|
US4201770A
(en)
|
1973-05-07 |
1980-05-06 |
The Ohio State University |
Antigenic modification of polypeptides
|
|
US4762913A
(en)
|
1973-05-07 |
1988-08-09 |
The Ohio State University |
Antigenic modification of polypeptides
|
|
US4526716A
(en)
|
1981-11-20 |
1985-07-02 |
The Ohio State University |
Antigenic modification of polypeptides
|
|
US4384995A
(en)
|
1980-01-16 |
1983-05-24 |
The Ohio State University |
Antigenic modification of polypeptides
|
|
US4069313A
(en)
|
1974-11-19 |
1978-01-17 |
Merck & Co., Inc. |
Water-in-oil adjuvant composition
|
|
US4196265A
(en)
|
1977-06-15 |
1980-04-01 |
The Wistar Institute |
Method of producing antibodies
|
|
SU1414392A1
(ru)
|
1982-12-29 |
1988-08-07 |
Всесоюзный кардиологический научный центр АМН СССР |
Противо звенное средство
|
|
US4925922A
(en)
|
1983-02-22 |
1990-05-15 |
Xoma Corporation |
Potentiation of cytotoxic conjugates
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4828991A
(en)
|
1984-01-31 |
1989-05-09 |
Akzo N.V. |
Tumor specific monoclonal antibodies
|
|
US4894443A
(en)
|
1984-02-08 |
1990-01-16 |
Cetus Corporation |
Toxin conjugates
|
|
CA1289077C
(en)
|
1984-08-13 |
1991-09-17 |
Harry H. Leveen |
Treatment of cancer with phlorizin and its derivatives
|
|
FR2575164B1
(fr)
|
1984-12-20 |
1987-03-20 |
Sanofi Sa |
Esters de tri- et tetrapeptides inhibiteurs de la secretion gastrique, procede d'obtention et compositions pharmaceutiques les contenant
|
|
IT1179894B
(it)
|
1984-12-27 |
1987-09-16 |
Rotta Research Lab |
Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche
|
|
US4803170A
(en)
|
1985-05-09 |
1989-02-07 |
Ultra Diagnostics Corporation |
Competitive immunoassay method, device and test kit
|
|
US4713366A
(en)
|
1985-12-04 |
1987-12-15 |
The Ohio State University Research Foundation |
Antigenic modification of polypeptides
|
|
IT1204430B
(it)
|
1986-01-10 |
1989-03-01 |
Alfio Bertolini |
Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
|
|
CA1341281C
(en)
|
1986-07-09 |
2001-08-07 |
Hubert J.P. Schoemaker |
Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen
|
|
US5344919A
(en)
|
1987-02-19 |
1994-09-06 |
The Scripps Research Institute |
Integrin from human epithelial cells
|
|
US4971792A
(en)
|
1987-03-27 |
1990-11-20 |
The Wistar Institute |
Monoclonal antibodies against glycolipid antigens
|
|
US4923819A
(en)
|
1987-03-27 |
1990-05-08 |
Chimerix Corporation |
Time-resolved fluorescence immunoassay
|
|
WO1989005156A1
(en)
|
1987-12-09 |
1989-06-15 |
The General Hospital Corporation |
Carcinoma-associated antigens, and antibodies which recognize these antigens
|
|
US5035988A
(en)
|
1988-05-12 |
1991-07-30 |
Fuji Photo Film Co., Ltd. |
Silver halide photographic material containing a yellow coupler and a phosphorus compound and color image forming method
|
|
US5162504A
(en)
|
1988-06-03 |
1992-11-10 |
Cytogen Corporation |
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
|
|
JPH0249596A
(ja)
|
1988-08-09 |
1990-02-19 |
Masamichi Ueda |
ヒト前立腺上皮細胞の表面に特異的に反応するモノクローナル抗体
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5759791A
(en)
|
1989-01-17 |
1998-06-02 |
The Johns Hopkins University |
Cancer related antigen
|
|
US5023077A
(en)
|
1989-01-24 |
1991-06-11 |
Aphton Corporation |
Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease
|
|
ES2063912T3
(es)
*
|
1989-01-24 |
1995-01-16 |
Aphton Corp |
Composiciones inmunogenicas frente a peptidos de gastrina.
|
|
US5120829A
(en)
|
1989-03-20 |
1992-06-09 |
La Jolla Cancer Research Foundation |
Hydrophobic attachment site for adhesion peptides
|
|
US4997950A
(en)
|
1989-04-20 |
1991-03-05 |
Richard Finbar Murphy |
Novel C-terminal gastrin antagonists
|
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
|
US5770576A
(en)
|
1989-08-30 |
1998-06-23 |
Cytran, Inc. |
Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
|
|
US5110911A
(en)
|
1989-11-02 |
1992-05-05 |
Biomira, Inc. |
Human tumor-associated thomsen-friedenreich antigen
|
|
US5164299A
(en)
|
1990-03-20 |
1992-11-17 |
E. I. Du Pont De Nemours And Company |
Use of a mixture of conjugated and unconjugated solid phase binding reagent to enhance the performance of assays
|
|
US5932412A
(en)
|
1990-05-11 |
1999-08-03 |
Euro-Diagnostica Ab |
Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes
|
|
US5733790A
(en)
|
1991-01-15 |
1998-03-31 |
The Salk Institute For Biological Studies |
CRF binding protein antibodies and assays using same
|
|
US5668117A
(en)
|
1991-02-22 |
1997-09-16 |
Shapiro; Howard K. |
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
|
|
US6251581B1
(en)
|
1991-05-22 |
2001-06-26 |
Dade Behring Marburg Gmbh |
Assay method utilizing induced luminescence
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
GB9115364D0
(en)
|
1991-07-16 |
1991-08-28 |
Wellcome Found |
Antibody
|
|
US5319073A
(en)
|
1992-02-07 |
1994-06-07 |
The United States Of America, As Represented By The Department Of Health & Human Services |
Method of purifying cholecystokinin receptor protein
|
|
US5256542A
(en)
|
1992-03-09 |
1993-10-26 |
Tanox Biosystems, Inc. |
Selecting low frequency antigen-specific single B lymphocytes with correction for background noise
|
|
US5580563A
(en)
|
1992-05-01 |
1996-12-03 |
Tam; James P. |
Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
|
|
DE69317282D1
(de)
|
1992-05-08 |
1998-04-09 |
Receptagen Corp |
Anti-Rezeptor Antikörper gegen den Vitamin B12/transcobalamin II Rezeptor
|
|
US5639613A
(en)
|
1992-05-13 |
1997-06-17 |
Board Of Regents, University Of Texas System |
Methods for cancer diagnosis and prognosis
|
|
DE69333623T3
(de)
|
1992-06-23 |
2014-05-15 |
Mount Sinai School Of Medicine |
Klonierung und expression von gonadotropinreleasing hormon
|
|
US5736146A
(en)
|
1992-07-30 |
1998-04-07 |
Yeda Research And Development Co. Ltd. |
Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them
|
|
JP3439490B2
(ja)
|
1992-09-28 |
2003-08-25 |
株式会社林原生物化学研究所 |
蛋白質とその蛋白質をコードするｄｎａ並びにその蛋白質の製造方法
|
|
JP3628029B2
(ja)
|
1992-09-30 |
2005-03-09 |
塩野義製薬株式会社 |
ガストリン拮抗剤の新用途
|
|
ATE373486T1
(de)
|
1992-09-30 |
2007-10-15 |
Univ Ohio State Res Found |
Impfstoffe zur behandlung von kolonkrebs
|
|
US5879898A
(en)
|
1992-11-20 |
1999-03-09 |
Isis Innovation Limited |
Antibodies specific for peptide corresponding to CD44 exon 6, and use of these antibodies for diagnosis of tumors
|
|
US5683695A
(en)
|
1993-02-10 |
1997-11-04 |
United Biomedical, Inc. |
Production of recombinant proteins containing multiple antigenic determinants linked by flexible hinge domains
|
|
US5759551A
(en)
|
1993-04-27 |
1998-06-02 |
United Biomedical, Inc. |
Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
|
|
CA2168584C
(en)
|
1993-08-09 |
2008-10-14 |
Edward Baral |
A method for sensitization of cancer cells for killer cell mediated lysis
|
|
US5601990A
(en)
|
1994-09-13 |
1997-02-11 |
Thomas Jefferson University |
Methods of diagnosing colorectal tumors and metastasis thereof
|
|
US5468494A
(en)
|
1993-11-12 |
1995-11-21 |
Aphton Corp. |
Immunogenic compositions against human gastrin 17
|
|
US5750119A
(en)
|
1994-01-13 |
1998-05-12 |
Mount Sinai School Of Medicine Of The City University Of New York |
Immunotherapeutic stress protein-peptide complexes against cancer
|
|
AU1681095A
(en)
|
1994-01-14 |
1995-08-01 |
Matthias Rath |
Hydrophilic signal oligopeptides and methods of therapeutic use
|
|
US7300918B2
(en)
|
1994-01-14 |
2007-11-27 |
Matthias Rath |
Method of producing vaccines from protein signal oligopeptides
|
|
US5688506A
(en)
|
1994-01-27 |
1997-11-18 |
Aphton Corp. |
Immunogens against gonadotropin releasing hormone
|
|
WO1995021380A1
(en)
|
1994-02-02 |
1995-08-10 |
Ludwig Institute For Cancer Research |
Assay for screening of receptor antagonists
|
|
US5767242A
(en)
|
1994-04-20 |
1998-06-16 |
Boehringer Ingelheim Int'l Gmbh |
Isolated dimeric fibroblast activation protein alpha, and uses thereof
|
|
US5869058A
(en)
|
1994-05-25 |
1999-02-09 |
Yeda Research And Development Co. Ltd. |
Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
|
|
CA2195753C
(en)
|
1994-07-25 |
2008-12-16 |
Ursula-Henrike Wienhues |
Determination of a specific immunoglobulin using multiple antigens
|
|
JP3853384B2
(ja)
|
1994-09-09 |
2006-12-06 |
株式会社三菱化学ヤトロン |
抗サイモシンα１モノクローナル抗体産生ハイブリドーマ
|
|
US5789000A
(en)
|
1994-11-14 |
1998-08-04 |
Bionumerik Pharmaceuticals, Inc. |
Sterile aqueous parenteral formulations of cis-diammine dichloro platinum
|
|
FI97304C
(fi)
|
1994-11-16 |
1996-11-25 |
Locus Genex Oy |
Menetelmä mahasyövän riskin seulonnaksi
|
|
US5723718A
(en)
|
1994-12-20 |
1998-03-03 |
St. Joseph's Hospital And Medical Center |
Induction of immune tolerance to tumor cells
|
|
US5955504A
(en)
|
1995-03-13 |
1999-09-21 |
Loma Linda University Medical Center |
Colorectal chemoprotective composition and method of preventing colorectal cancer
|
|
US7078493B1
(en)
|
1995-03-15 |
2006-07-18 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor-like genes
|
|
EP0824596A1
(en)
|
1995-05-12 |
1998-02-25 |
Schering Corporation |
Surface plasmon resonance based enzymatic assay
|
|
US6359114B1
(en)
|
1995-06-07 |
2002-03-19 |
Aphton Corp. |
System for method for the modification and purification of proteins
|
|
US5811097A
(en)
|
1995-07-25 |
1998-09-22 |
The Regents Of The University Of California |
Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
|
|
US5712369A
(en)
|
1995-08-24 |
1998-01-27 |
Ludwig Institute For Cancer Research |
Isolated protein which binds to A33 antibody, and peptides corresponding to portions of the protein
|
|
DE69602756T2
(de)
|
1995-08-18 |
2000-02-10 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Rockville |
Funktionelle rolle von adrenomedullin(am) und dem gen-verwandten produkt(pamp) in der menschlichen pathologie und physiologie
|
|
MA24512A1
(fr)
|
1996-01-17 |
1998-12-31 |
Univ Vermont And State Agrienl |
Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose
|
|
ATE505202T1
(de)
|
1996-02-08 |
2011-04-15 |
Cancer Advances Inc |
Immunologische methoden zur behandlung von gastrointestinalem krebs
|
|
US5786213A
(en)
|
1996-04-18 |
1998-07-28 |
Board Of Regents, The University Of Texas System |
Inhibition of endogenous gastrin expression for treatment of colorectal cancer
|
|
CA2257108A1
(en)
|
1996-06-07 |
1997-12-11 |
Takeda Chemical Industries, Ltd. |
Novel peptides and production and use thereof
|
|
IL118626A0
(en)
|
1996-06-11 |
1996-10-16 |
Xtl Biopharmaceuticals Limited |
Anti HBV antibody
|
|
JPH1026621A
(ja)
|
1996-07-12 |
1998-01-27 |
Dai Ichi Pure Chem Co Ltd |
イムノアッセイ法
|
|
UA76934C2
(en)
|
1996-10-04 |
2006-10-16 |
Chugai Pharmaceutical Co Ltd |
Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody
|
|
US6472506B1
(en)
|
1997-01-21 |
2002-10-29 |
Aventis Pasteur S.A. |
Polysaccharide-peptide-conjugates
|
|
WO1998035707A1
(en)
|
1997-02-18 |
1998-08-20 |
Thomas Jefferson University |
Compositions that bind to pancreatic cancer cells and methods of using the same
|
|
US20040001842A1
(en)
|
1997-05-12 |
2004-01-01 |
Dov Michaeli |
Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
|
|
ES2227833T3
(es)
|
1997-05-12 |
2005-04-01 |
Aphton Corporation |
Composiciones inmunogenicas para el receptor cck-b/gastrina y metodos para el tratamiento de tumores.
|
|
AUPO982097A0
(en)
|
1997-10-15 |
1997-11-06 |
University Of Melbourne, The |
Methods and compositions for use therein
|
|
US6565813B1
(en)
|
1998-02-04 |
2003-05-20 |
Merck & Co., Inc. |
Virtual wells for use in high throughput screening assays
|
|
EP1579863A3
(en)
|
1998-05-15 |
2008-03-19 |
Receptor Biologix, Inc. |
Combination therapy with anti-gastrin G17 antibodies for the treatment of tumors
|
|
KR100699574B1
(ko)
|
1998-05-15 |
2007-03-23 |
리셉터 바이오로직스 인크 |
종양 치료를 위한 조합 치료
|
|
AU4080399A
(en)
|
1998-05-15 |
1999-12-06 |
Aphton Corporation |
Prevention and treatment of hypergastrinemia
|
|
US20030068326A1
(en)
|
1998-05-15 |
2003-04-10 |
Aphton Corporation |
Method for the treatment of gastroesophageal reflux disease
|
|
CA2331834A1
(en)
|
1998-06-18 |
1999-12-23 |
Michal Y. Chowers |
Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
|
|
DE19956568A1
(de)
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
|
AU768027B2
(en)
|
1999-02-24 |
2003-11-27 |
Uab Research Foundation, The |
Taxane derivatives for targeted therapy of cancer
|
|
FI118653B
(fi)
|
1999-04-30 |
2008-01-31 |
Biohit Oyj |
Menetelmä peptisen haavan riskin määrittämiseksi
|
|
FR2797689B1
(fr)
|
1999-08-16 |
2003-06-27 |
Pasteur Sanofi Diagnostics |
Utilisation de composes synthetiques pour des immunodosages
|
|
TR200200472T2
(tr)
|
1999-08-27 |
2002-06-21 |
Genentech, Inc. |
Anti-Erb B2 antikorları ile tedavi için dozajlar
|
|
WO2001034192A2
(en)
|
1999-11-08 |
2001-05-17 |
Aphton Corporation |
Improved method of immunization
|
|
US20020058040A1
(en)
|
1999-12-23 |
2002-05-16 |
Stephen Grimes |
Stable immunogenic composition for frozen storage
|
|
WO2001077685A2
(en)
|
2000-04-10 |
2001-10-18 |
The General Hospital Corporation |
Diagnosis and treatment of gastrointestinal disease
|
|
US20030138860A1
(en)
|
2000-06-14 |
2003-07-24 |
Robertson John Forsyth Russell |
Cancer detection methods and reagents
|
|
US20030232399A1
(en)
|
2000-06-14 |
2003-12-18 |
Robertson John Forsyth Russell |
Cancer detection methods and reagents
|
|
US6780969B2
(en)
|
2000-12-22 |
2004-08-24 |
United Biomedical, Inc. |
Synthetic peptide composition as immunogens for prevention of urinary tract infection
|
|
CN1312181C
(zh)
|
2001-02-12 |
2007-04-25 |
米德列斯公司 |
抗Fcα受体(CD89)的人单克隆抗体
|
|
JP2005508838A
(ja)
|
2001-03-23 |
2005-04-07 |
アフトン コーポレーション |
膵癌の組合せ治療
|
|
US20090191232A1
(en)
|
2001-05-04 |
2009-07-30 |
Gevas Philip C |
Combination therapy for the treatment of tumors
|
|
JP2004536835A
(ja)
|
2001-07-09 |
2004-12-09 |
アフトン コーポレーション |
肝臓、肺および食道の癌性ならびに前癌性状態の治療および防止
|
|
BRPI0214168B8
(pt)
|
2001-11-14 |
2021-05-25 |
Centocor Inc |
anticorpos anti-il-6, moléculas de ácido nucleico codificando os mesmos, vetores compreendendo as referidas moléculas, composições e formulações compreendendo os referidos anticorpos, bem como métodos de produção dos mesmos
|
|
EP1837031B1
(en)
|
2002-06-07 |
2009-10-14 |
Waratah Pharmaceuticals, Inc. |
Compositions and methods for treating diabetes
|
|
US20050169979A1
(en)
|
2002-07-03 |
2005-08-04 |
Dov Michaeli |
Liposomal vaccine
|
|
US20040208920A1
(en)
|
2002-07-03 |
2004-10-21 |
Dov Michaeli |
Liposomal vaccine
|
|
US20040247661A1
(en)
|
2002-07-03 |
2004-12-09 |
Dov Michaeli |
Liposomal vaccine
|
|
ES2350687T3
(es)
|
2002-07-03 |
2011-01-26 |
Ono Pharmaceutical Co., Ltd. |
Composiciones de inmunopotenciación.
|
|
FI119571B
(fi)
|
2002-09-06 |
2008-12-31 |
Biohit Oyj |
Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä
|
|
US20030049698A1
(en)
|
2002-10-08 |
2003-03-13 |
Wang Timothy C. |
Diagnosis and treatment of gastrointestinal disease
|
|
US7438907B2
(en)
|
2002-11-15 |
2008-10-21 |
Genmab A/S |
Human monoclonal antibodies against CD25
|
|
JP4689597B2
(ja)
|
2003-03-28 |
2011-05-25 |
レセプター バイオロジックス インク． |
ガストリンホルモン免疫アッセイ
|
|
WO2004089976A1
(en)
|
2003-04-08 |
2004-10-21 |
The University Of Melbourne |
Method of treatment
|
|
EP1730193A2
(en)
|
2004-03-29 |
2006-12-13 |
Receptor Biologix, Inc. |
Monoclonal antibodies to gastrin hormone
|
|
CN1997669A
(zh)
|
2004-03-29 |
2007-07-11 |
受体生物技术公司 |
抗胃泌素激素单克隆抗体
|
|
WO2006008649A1
(en)
|
2004-07-15 |
2006-01-26 |
Aphton Corporation |
Anti-sense polynucleotide therapy for gastrin-promoted tumors
|
|
AU2005270917A1
(en)
|
2004-08-11 |
2006-02-16 |
Cancer Advances, Inc. |
Gastrin-specific interfering RNA
|
|
US7662926B2
(en)
|
2004-09-02 |
2010-02-16 |
Genentech, Inc. |
Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor
|
|
KR101333168B1
(ko)
|
2004-09-22 |
2013-11-28 |
리셉터 바이오로직스 인크 |
프로가스트린에 대한 모노클로날 항체
|
|
EP1971363A1
(en)
|
2005-12-02 |
2008-09-24 |
Waratah Pharmaceuticals, Inc. |
Combination treatments with gastrin agonists for diabetes and related diseases
|
|
CN100558747C
(zh)
*
|
2006-04-06 |
2009-11-11 |
海南天源康泽医药科技有限公司 |
以白喉毒素突变体crm197为载体的免疫原及其制备方法与应用
|
|
US7854932B2
(en)
|
2006-12-19 |
2010-12-21 |
The Board Of Regents Of The University Of Texas System |
Immunogenic compositions comprising progastrin and uses thereof
|
|
EP3375791A1
(en)
|
2009-09-30 |
2018-09-19 |
Memorial Sloan Kettering Cancer Center |
Combination immunotherapy for the treatment of cancer
|
|
US8900588B2
(en)
*
|
2010-01-08 |
2014-12-02 |
Les Laboratories Servier |
Methods for treating breast cancer
|
|
GB201121571D0
(en)
*
|
2011-12-15 |
2012-01-25 |
Astrimmune Ltd |
Compounds and uses thereof
|
|
ES2665780T3
(es)
|
2013-05-21 |
2018-04-27 |
Tyg Oncology Ltd. |
Composición inmunogénica de péptido de gastrina
|
|
CN104232576B
(zh)
|
2013-06-14 |
2018-07-17 |
加思葆（北京）医药科技有限公司 |
蛋白-细胞偶联物、其制备方法和用途
|
|
WO2015069571A1
(en)
*
|
2013-11-05 |
2015-05-14 |
Bavarian Nordic, Inc. |
Combination therapy for treating cancer with a poxvirus expressing a tumor antigen and an antagonist and/or agonist of an immune checkpoint inhibitor
|
|
MX2017015618A
(es)
*
|
2015-06-03 |
2018-08-15 |
Boston Biomedical Inc |
Composiciones que comprenden un inhibidor de la autorrenovación y diferenciación de células madre cancerosas y un agente inmunoterapéutico para su uso en el tratamiento del cáncer.
|
|
US12150978B2
(en)
|
2017-06-15 |
2024-11-26 |
Cancer Advances Inc. |
Compositions and methods for preventing tumors and cancer
|
|
WO2018232230A1
(en)
|
2017-06-15 |
2018-12-20 |
Cancer Advances Inc. |
Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
|
|
JP2024504924A
(ja)
|
2021-01-13 |
2024-02-02 |
キャンサー アドヴァンシーズ インク． |
腫瘍及びがんを予防するための組成物及び方法
|